Skip to content

The effect of analgesic effects and time on maternal fever during patient-controlled epidural analgesia

The effect of analgesic effects and time on maternal fever during patient-controlled epidural analgesia:An observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102872
Enrollment
Unknown
Registered
2025-05-21
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

maternal fever

Interventions

Fever group:None
No-fever group:None

Sponsors

Hangzhou First People´s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. primipara with full-term singleton pregnancy(> 37 weeks) and vertex presentation; 2. vaginal in-hospital delivery assisted by the obstetrician; 3. willingness to use PCEA and no contraindication of epidural puncture or related drug allergy history; 4. maternity with an American Society of Anesthesiologists (ASA) class I or II.

Exclusion criteria

Exclusion criteria: 1. baseline body temperature >37.5°C; 2. maternity with autoimmune disease, septicemia, cephalomeningitis, pneumonia disease; 3. history of lower genital tract infection,maternal hepatitis, or HIV infection; 4. taking steroids before the study; 5. cesarean section due to emergency situations.

Design outcomes

Primary

MeasureTime frame
Epidural labor analgesia related data;

Secondary

MeasureTime frame
Parturition temperature;delivery outcome;Drug use;

Countries

China

Contacts

Public ContactHuang Yaqin

Hangzhou First People´s Hospital

1021648643@qq.com+86 158 5824 3148

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026